Vivacit-E Liner for Hip Osteoarthritis
Recruiting in Palo Alto (17 mi)
+4 other locations
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Zimmer Biomet
No Placebo Group
Trial Summary
What is the purpose of this trial?
This trial is testing a special hip replacement part made from durable plastic in patients needing hip surgery. The goal is to see if it reduces wear and tear, improves pain, and enhances movement.
Research Team
RB
Ryan Boylan, MBA
Principal Investigator
Zimmer Biomet
Eligibility Criteria
This trial is for adults aged 18-60 with hip conditions like osteoarthritis or avascular necrosis who need a new hip joint (total hip arthroplasty). They must be skeletally mature, have not had previous hip replacements on the affected side, and be able to follow the study's procedures and visits.Inclusion Criteria
I am willing and able to follow the required treatment after surgery.
I am between 18 and 60 years old.
My bones have stopped growing.
See 11 more
Exclusion Criteria
The patient is known to be pregnant
I have been diagnosed with Rheumatoid Arthritis.
I am currently dealing with an infection.
See 12 more
Treatment Details
Interventions
- Vivacit-E Liner (Polyethylene Liner)
Trial OverviewThe Vivacit-E Liner used in total hip replacements is being studied. Researchers want to see how well it performs by looking at wear over time, patient outcomes through surveys and x-rays, and any reported problems.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Vivacit-E LinerExperimental Treatment1 Intervention
All subjects enrolled receive the study implant.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zimmer Biomet
Lead Sponsor
Trials
383
Recruited
67,800+
Dr. Nitin Goyal
Zimmer Biomet
Chief Medical Officer since 2021
MD from Harvard Medical School
Ivan Tornos
Zimmer Biomet
Chief Executive Officer since 2023
MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business